The squalid history of medical patents
Bringing medicines into the global intellectual property regime was a triumph of corporate skulduggery led by Pfizer
COVID-19: How is expiration date of vaccines determined?
Expired vaccines are not particularly unsafe or dangerous, say experts
Pfizer wants to sell vaccines in India at no profit
The Pfizer vaccine is yet to be registered in India although it had applied months ago
How Rwanda reached first global COVID-19 vaccination target
Rwanda defined a vaccination plan prior to getting the vaccines
Global COVID-19 cases set to triple with over 3 billion omicron infections in coming 2-3 months: IHME
Australia and New Zealand may experience their worst outbreaks of this pandemic
New Delta+ variant found in India can escape antibodies
Mutations in the Delta+ variant can render vaccines and treatments ineffective
Lateral Thoughts: Waiting for the vaccine?
Vaccination programmes cannot be dealt with outside the purview of public health
Pfizer withdraws application for Emergency Use Authorisation in India
The company will resubmit application after getting more data
Omicron may already be in most countries, WHO warns
People dismissing omicron infection as mild may fuel spread, says WHO
Experts suggest updating vaccines for new variants. How does it work & what are the challenges?
It is easier to update certain vaccine platforms than others, say experts
Strong medicine for weak drug patents
Revocation of Pfizer, Roche patents for lacking inventive step signals healthy trend
Make unethical drug trials a punishable offence, say experts
Current laws do not fix penalty if such practices are found
Drug trials: Irked NHRC issues notices to Centre and Andhra Pradesh government
Says respond else face action
US piles on the pressure
Patent law, domestic content rules in solar and ICT policy come under attack
Post-pandemic blues of predatory pharma
Huge stockpiles of COVID-19 vaccines and treatments, along with a steep drop in revenues, tell a sorry tale of Big Pharma’s greed
Moderna strikes with a new lawsuit
Moderna is trying to be gatekeeper for the mRNA platform for future drug development, raising monopolistic fears
Why the US and its allies are stupid to turn COVID-19 vaccination into a geopolitical power play
The COVID-19 pandemic demands that all nations cooperate to vaccinate the entire global population—a goal that can’t be achieved …
Charity after profiteering, the Big Pharma way
Pfizer to sell its medicines at no profit in world’s poorest countries, and other big names to make cancer drugs more accessible
Rwanda and Senegal will host Africa’s first COVID-19 vaccine plants: What’s known so far
Only Tunisia, Senegal, Egypt, Ethiopia, and South Africa have varying capabilities to produce and fill or finish vaccines
Norway reports deaths related to COVID-19 vaccination
Situation not alarming, only ‘small exception’ affected by Pfizer mRNA vaccine: Medical director of Norwegian Medicines Agency
Viva Cuba for its vaccine revolution
Punching way above its weight, the tiny nation has developed five vaccines, and offers hope of vaccine equity across the world
90% efficacy for Pfizer’s COVID-19 mRNA vaccine is striking. But we need to wait for the full data
Important questions remain: It’s unclear how long protection will last and if the vaccine protects against severe disease
Lateral thoughts: COVID-19 vaccines and a game of chance
Would you be compensated for adverse reactions to the COVID-19 vaccines?
COVID-19: Has Big Pharma enabled the rise of omicron
Major drug companies do not want to share the know-how for their vaccines; uneven global vaccine access is now resulting in …
COVID-19 vaccines: Is foreign good for India
The decision to allow foreign vaccines in India may not take plug the current shortage